CARE Ratings Limited — Others, 17-06-2025: Shareholders meeting

CARE Ratings Limited has announced a board meeting on July 10, 2025, to consider the financial results for the quarter and half-year. The company reported its highest-ever consolidated revenue of Rs 402.3 Cr in FY25, up 21% year-on-year, driven by volume growth, improved realisations, and greater contribution from international subsidiaries and advisory services. Ratings contributed 89.5% of revenue with 10.5% from non-ratings segments. The standalone net profit rose 24% to Rs 148 Cr, with an 18.9% increase in standalone revenues to Rs 337 Cr. The Board recommends a final dividend of Rs 11 per share, in addition to an interim dividend of Rs 7 per share. Key operational highlights include a verticalised business development model, 55% growth in securitisation rated volumes, leadership in monitoring proceeds of equity issuances, and expanding international footprint via subsidiaries in Africa, Nepal, South Africa, and the launch of CareEdge Global IFSC for global scale and sovereign ratings. Technology investments advanced with AI/ML-enabled platforms, including EdgeAvira.ai for credit risk solutions. The company’s CSR spend was Rs 2.75 Cr, focusing on healthcare, education, women empowerment, and support for defence personnel. Senior management and independent directors bring diverse expertise in finance, technology, regulation, and global markets. No material regulatory or legal hurdles were reported impacting continuity or operations. Key management remuneration saw increases aligned with company performance. The company maintains robust governance, comprehensive risk management, and a transparent stakeholder engagement program.